New Inpatient Visitor Check-In Process Effective March 10. Learn more here.
Jason A. Damsker, MD, FACP
Specialties
- Medical Oncology
Clinical Locations
-
Fox Chase Cancer Center - Chestnut Hill8835 Germantown Avenue
Philadelphia, PA 19118
Phone: 888-369-2427
-
Fox Chase Cancer Center - Buckingham2365 Heritage Center Drive
Furlong, PA 18925
Phone: 888-369-2427
Educational Background
- Fox Chase/Temple Hematology Oncology Fellowship Philadelphia, PA July 2000 – June 2003
- Temple University Hospital Internal Medicine Residency Philadelphia, PA June 1997 - June 2000
- M.D., Hahnemann University School of Medicine Philadelphia, PA August 1993 - May 1997
- B.A., Cornell University, Chemistry and Classics, with Distinction in all subjects, Ithaca, NY August 1989 - May 1993
Certifications
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Hematology
- American Board of Internal Medicine - Medical Oncology
Honors & Awards
- PRACTICE: Philadelphia Magazine Top Doctors ™ 2018, 2019, 2020, 2021, 2022, 2023, 2024 in Medical Oncology
- FELLOWSHIP: ASCO Merit Award Recipient, May 2003
- RESIDENCY: I. Ginsberg Award for Teaching Excellence, May 2000
- MEDICAL SCHOOL: Alpha Omega Alpha, Zeta Chapter, March 1996 Measey Foundation Scholarship, 1995-6 General Scholarship Fund Scholarship, 1994-5 St. George Medical Cancer Society Fellowship in Hematology/Oncology under preceptorship of Pamela Crilley, DO, Hahnemann University Hospital, June-July 1994 Edward Calabrese Scholarship, 1993-4 Mary English Scholarship, 1993-4
- COLLEGE: Phi Beta Kappa, Theta Chapter, inducted 1993 Golden Key Honor Society, inducted 1991
Selected Publications
Won J, Zhao E, States M, Brown R, El-Habr A, Damsker J. Pembrolizumab-induced Myasthenia Gravis and Myocarditis. J Community Hosp Intern Med Perspect. 2024 May 7;14(3):85-88. doi: 10.55729/2000-9666.1352. eCollection 2024. PMID: 39036582
Willard PJ, Damsker JA, Pickens PV. Effects of Green Tea of Various Types of Indolent Low Grade B-Cell Lymphomas. Blood (2020) 136 (Supple 1): 15-16.
Micaily I, Gagnon M-H, Friedenheim R, Damsker JA. A Rare Case of Hemophagocytic Lymphohistocytosis of Unknown Etiology. Blood 2017 130: no. Supple 1 4831.
Josep Tabernero et al. + RAISE Study Investigators (one of the RAISE Study Investigators, J. Damsker). Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study. Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12
Pasi A. Janne, MD, PhD, Antoinette J. Wozniak, MD, Chandra P. Belani, MD, et al, on behalf of pemetrexed expanded access program investigators (one of the Pemetrexed EAP investigators, J Damsker). Pemetrexed Alone or in Combination with Cisplatin in Previously Treated Malignant Pleural Mesothelioma: Outcomes from a Phase IIIB Pemetrexed Expanded Access Program. J Thorac Oncol 2006 Jul;1(6):506-12.
Kramer NM, Horwitz EM, Cheng J, Ridge JA, Feigenberg SJ, Nicolau N, Sherman EJ, Babb JS, Damsker JA, Langer CJ. Toxicity and Outcome Analysis of Patients with Recurrent Head and Neck Cancer Treated with Hyperfractionated Split-course Reirraadiation and Concurrent Cisplatin and Paclitaxel Chemotherapy from Two Prospective Phase I and II Studies. Head Neck. 27:406-14. May 2005.
Langer C, Damsker J, Ridge A. Reirradiation: Exploring New Territory in the Therapy of Recurrent Head and Neck Cancer. Clinical Advances in Hematology & Oncology. 1(7):424-429, 440. July 2003.
Patient comments